BROADCASTS.com

b'Today we\\u2019re joined by Kim Branson, the SVP and global head of artificial intelligence and machine learning at GSK.\\xa0\\nWe cover a lot of ground in our conversation, starting with a breakdown of GSK\\u2019s core pharmaceutical business, and how ML/AI fits into that equation, use cases that appear using genetics data as a data source, including sequential learning for drug discovery. We also explore the 500 billion node knowledge graph Kim\\u2019s team built to mine scientific literature, and their \\u201cAI Hub\\u201d, the ML/AI infrastructure team that handles all tooling and engineering problems within their organization. Finally, we explore their recent cancer research collaboration with King\\u2019s College, which is tasked with understanding the individualized needs of high- and low-risk cancer patients using ML/AI amongst other technologies.\\xa0\\nThe complete show notes for this episode can be found at twimlai.com/go/536.'